ArticleJACS Au2026
Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design.
Yu Wen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleJACS Au2026
Yu Wen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.